Helus Pharma Inc. (formerly, Cybin Inc.)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bartlone, Aaron Frank Senior Officer of Issuer Officer
Transaction date
Sale
Price
56.66
Quantity 28,164 -20.5%
Value US$1,359,939
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-19 2026-10-19 S Sale

Senior Officer of Issuer

Officer
28,164 -20.5%
56.66
US$1,359,939
28,164 -20.5% 56.66 US$1,359,939
Explore more

More insider trading research around Helus Pharma Inc. (formerly, Cybin Inc.)